- Home
- PMCB vs EKSO Comparison
PMCB vs EKSO Comparison
Compare PMCB & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- EKSO
- Stock Information
- Founded
- PMCB 1996
- EKSO 2005
- Country
- PMCB United States
- EKSO United States
- Employees
- PMCB N/A
- EKSO N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- EKSO Medical/Dental Instruments
- Sector
- PMCB Health Care
- EKSO Health Care
- Exchange
- PMCB Nasdaq
- EKSO Nasdaq
- Market Cap
- PMCB 13.9M
- EKSO 14.9M
- IPO Year
- PMCB N/A
- EKSO N/A
- Fundamental
- Price
- PMCB $1.62
- EKSO $0.70
- Analyst Decision
- PMCB
- EKSO Strong Buy
- Analyst Count
- PMCB 0
- EKSO 2
- Target Price
- PMCB N/A
- EKSO $5.50
- AVG Volume (30 Days)
- PMCB 13.7K
- EKSO 133.9K
- Earning Date
- PMCB 12-24-2024
- EKSO 10-28-2024
- Dividend Yield
- PMCB N/A
- EKSO N/A
- EPS Growth
- PMCB N/A
- EKSO N/A
- EPS
- PMCB 0.74
- EKSO N/A
- Revenue
- PMCB N/A
- EKSO $17,682,000.00
- Revenue This Year
- PMCB N/A
- EKSO $1.11
- Revenue Next Year
- PMCB N/A
- EKSO $38.63
- P/E Ratio
- PMCB $2.25
- EKSO N/A
- Revenue Growth
- PMCB N/A
- EKSO 4.12
- 52 Week Low
- PMCB $1.39
- EKSO $0.50
- 52 Week High
- PMCB $2.58
- EKSO $3.13
- Technical
- Relative Strength Index (RSI)
- PMCB 45.07
- EKSO 52.12
- Support Level
- PMCB $1.61
- EKSO $0.50
- Resistance Level
- PMCB $1.81
- EKSO $0.75
- Average True Range (ATR)
- PMCB 0.11
- EKSO 0.06
- MACD
- PMCB 0.00
- EKSO 0.02
- Stochastic Oscillator
- PMCB 43.64
- EKSO 94.36
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.